Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Rating of “Moderate Buy” from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has received an average rating of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have issued a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $31.25.

A number of research analysts have recently issued reports on the stock. TD Cowen reduced their price objective on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a report on Friday, May 1st. Zacks Research cut shares of Option Care Health from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 price target on the stock. in a report on Friday, May 1st. JPMorgan Chase & Co. cut their price target on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating on the stock in a report on Monday, May 4th. Finally, Truist Financial set a $30.00 price target on shares of Option Care Health in a report on Friday, May 1st.

Option Care Health Stock Down 2.0%

Shares of NASDAQ OPCH opened at $20.46 on Tuesday. The stock has a market capitalization of $3.21 billion, a P/E ratio of 15.86, a P/E/G ratio of 1.16 and a beta of 0.67. The company has a 50-day moving average price of $24.96 and a 200-day moving average price of $29.77. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. Option Care Health had a net margin of 3.64% and a return on equity of 18.17%. The business’s revenue was up 1.3% on a year-over-year basis. During the same period last year, the company earned $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. On average, equities research analysts forecast that Option Care Health will post 1.64 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the completion of the acquisition, the director owned 450,000 shares in the company, valued at $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO John Charles Rademacher purchased 12,500 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The shares were purchased at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer owned 695,152 shares of the company’s stock, valued at $14,723,319.36. The trade was a 1.83% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have bought 73,264 shares of company stock worth $1,548,316. 1.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. V Square Quantitative Management LLC purchased a new position in Option Care Health during the fourth quarter worth about $25,000. Cornerstone Planning Group LLC raised its position in Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. McIlrath & Eck LLC bought a new stake in Option Care Health in the second quarter worth about $37,000. Advisory Services Network LLC bought a new stake in Option Care Health in the third quarter worth about $35,000. Finally, Caitong International Asset Management Co. Ltd bought a new stake in Option Care Health in the third quarter worth about $38,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.